leadf
logo-loader
TSX-V:VPT OTCQB:VPTDF

VentriPoint Diagnostics Ltd.

Receive alerts
Market:
TSX-V
Market Cap:
$6.62 m
Price
0.10 CAD
Change
-13.64%
52 weeks high
0.16
52 weeks low
0.07

In brief

Ventripoint’s technology is a leading Artificial Intelligence (AI) approach known as Knowledge-Based Reconstruction (KBR), used to create applications to monitor heart disease, a leading cause of death worldwide. The VMS+ is the first cost-effective and accurate AI tool for measuring whole heart function using conventional ultrasound. The Company has developed a suite of applications for all major heart diseases and is actively commercializing the approach to improve cardiac care.

Snapshot

The Ventripoint Medical System is the only approved way to generate substantially equivalent results to gold-standard MRI